Overview
Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section
Status:
Unknown status
Unknown status
Trial end date:
2019-05-01
2019-05-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The aim of the work is to assess the effect of combined misoprostol 200 mcg and isosorbide mononitrate 40 mg versus misoprostol 200 mcg and placebo as local vaginal tablet on the successful IUD insertion.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Assiut UniversityTreatments:
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Misoprostol
Criteria
Inclusion Criteria:We will include- Nonpregnant women,
- aged 18-45 years, .delivered before only by elective CS and did not receive any
analgesics in the 24 h prior to IUD insertion.
Exclusion Criteria:We will exclude
- Women with any uterine abnormalities as congenital anomalies,
- Women with endometrial lesions,
- Women with adenomyosis,
- Women with fibroids,
- Women with intrauterine adhesions,
- Women with chronic pelvic pain,
- Women with spasmodic dysmenorrhea,
- Women with abnormal uterine bleeding,
- Women with history of cervical surgery, .Women with allergy to misoprostol or
isosorbide mononitrate or any medical disease that contraindicates its use and those
who refused to participate in the study.